Skip to main content
Top
Published in: Journal of Cardiovascular Magnetic Resonance 1/2009

Open Access 01-12-2009 | Research

Biventricular adaptation to volume overload in mice with aortic regurgitation

Authors: Christopher J Berry, Jordan D Miller, KellyAnn McGroary, Daniel R Thedens, Stephen G Young, Donald D Heistad, Robert M Weiss

Published in: Journal of Cardiovascular Magnetic Resonance | Issue 1/2009

Login to get access

Abstract

Background

Aortic valve regurgitation is usually caused by impaired coaptation of the aortic valve cusps during diastole. Hypercholesterolemia produces aortic valve lipid deposition, fibrosis, and calcification in both mice and humans, which could impair coaptation of cusps. However, a link between hypercholesterolemia and aortic regurgitation has not been established in either species. The purpose of this study was to ascertain the prevalence of aortic regurgitation in hypercholesterolemic mice and to determine its impact on the left and right ventricles.

Methods and Results

Eighty Ldlr-/-/Apob100/100/Mttpfl/fl/Mx1Cre+/+ ("Reversa") hypercholesterolemic mice and 40 control mice were screened for aortic regurgitation (AR) with magnetic resonance imaging at age 7.5 months. The prevalence of AR was 40% in Reversa mice, with moderate or severe regurgitation (AR+) in 19% of mice. In control mice, AR prevalence was 13% (p = 0.004 vs. Reversa), and was invariably trace or mild in severity. In-depth evaluation of cardiac response to volume overload was performed in 12 AR-positive and 12 AR-negative Reversa mice. Regurgitant fraction was 0.34 ± 0.04 in AR-positive vs. 0.02 ± 0.01 in AR-negative (mean ± SE; p < 0.001). AR-positive mice had significantly increased left ventricular end-diastolic volume and mass and reduced ejection fraction in both ventricles. When left ventricular ejection fraction fell below 0.60 in AR-positive (n = 7) mice, remodeling occurred and right ventricular systolic function progressively worsened.

Conclusion

Hypercholesterolemia causes aortic valve regurgitation with moderate prevalence in mice. When present, aortic valve regurgitation causes volume overload and pathological remodeling of both ventricles.
Appendix
Available only for authorised users
Literature
1.
go back to reference Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL, Lehman B, Benjamin EJ: Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. 1999, 83: 897-902. 10.1016/S0002-9149(98)01064-9.CrossRefPubMed Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL, Lehman B, Benjamin EJ: Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. 1999, 83: 897-902. 10.1016/S0002-9149(98)01064-9.CrossRefPubMed
2.
go back to reference Borer JS, Bonow RO: Contemporary approach to aortic and mitral regurgitation. Circulation. 2003, 108: 2432-2438. 10.1161/01.CIR.0000096400.00562.A3.CrossRefPubMed Borer JS, Bonow RO: Contemporary approach to aortic and mitral regurgitation. Circulation. 2003, 108: 2432-2438. 10.1161/01.CIR.0000096400.00562.A3.CrossRefPubMed
3.
go back to reference Borer JS: Aortic Valve Replacement for the asymptomatic patient with aortic regurgitation: a new piece of the strategic puzzle. Circulation. 2002, 106: 2637-2639. 10.1161/01.CIR.0000040585.99021.8E.CrossRefPubMed Borer JS: Aortic Valve Replacement for the asymptomatic patient with aortic regurgitation: a new piece of the strategic puzzle. Circulation. 2002, 106: 2637-2639. 10.1161/01.CIR.0000040585.99021.8E.CrossRefPubMed
4.
go back to reference Roberts WC, Ko JM, Moore TR, Jones WH: Causes of pure aortic regurgitation in patients having isolated aortic valve replacement at a single US tertiary hospital (1993 to 2005). Circulation. 2006, 114: 422-429. 10.1161/CIRCULATIONAHA.106.622761.CrossRefPubMed Roberts WC, Ko JM, Moore TR, Jones WH: Causes of pure aortic regurgitation in patients having isolated aortic valve replacement at a single US tertiary hospital (1993 to 2005). Circulation. 2006, 114: 422-429. 10.1161/CIRCULATIONAHA.106.622761.CrossRefPubMed
5.
go back to reference Lieu HD, Withycombe SK, Walker Q, Rong JX, Walzem RL, Wong JS, Hamilton RL, Fisher EA, Young SG: Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion. Circulation. 2003, 107: 1315-1321. 10.1161/01.CIR.0000054781.50889.0C.CrossRefPubMed Lieu HD, Withycombe SK, Walker Q, Rong JX, Walzem RL, Wong JS, Hamilton RL, Fisher EA, Young SG: Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion. Circulation. 2003, 107: 1315-1321. 10.1161/01.CIR.0000054781.50889.0C.CrossRefPubMed
6.
go back to reference Weiss RM, Ohashi M, Miller JD, Young SG, Heistad DD: Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation. 2006, 114: 2065-2069. 10.1161/CIRCULATIONAHA.106.634139.CrossRefPubMed Weiss RM, Ohashi M, Miller JD, Young SG, Heistad DD: Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation. 2006, 114: 2065-2069. 10.1161/CIRCULATIONAHA.106.634139.CrossRefPubMed
7.
go back to reference Miller JD, Weiss RM, Serrano KM, Brooks RM, Berry CJ, Zimmerman K, Young SG, Heistad DD: Normalization of hypercholesterolemia halts progression of aortic valve disease in mice. Circulation. 2009, 119: 2693-701. 10.1161/CIRCULATIONAHA.108.834614.PubMedCentralCrossRefPubMed Miller JD, Weiss RM, Serrano KM, Brooks RM, Berry CJ, Zimmerman K, Young SG, Heistad DD: Normalization of hypercholesterolemia halts progression of aortic valve disease in mice. Circulation. 2009, 119: 2693-701. 10.1161/CIRCULATIONAHA.108.834614.PubMedCentralCrossRefPubMed
8.
go back to reference Akat K, Borggrefe M, Kaden JJ: Aortic valve calcification: basic science to clinical practice. Heart. 2009, 95: 616-623. 10.1136/hrt.2007.134783.CrossRefPubMed Akat K, Borggrefe M, Kaden JJ: Aortic valve calcification: basic science to clinical practice. Heart. 2009, 95: 616-623. 10.1136/hrt.2007.134783.CrossRefPubMed
9.
go back to reference Berry CJ, Thedens DR, Light-McGroary KA, Miller JD, Kutschke W, Zimmerman KA, Weiss RM: Effects of deep sedation or general anesthesia on cardiac function in mice undergoing cardiac magnetic resonance imaging. J Cardiovasc Magnet Res. 2009, 19: 16-10.1186/1532-429X-11-16.CrossRef Berry CJ, Thedens DR, Light-McGroary KA, Miller JD, Kutschke W, Zimmerman KA, Weiss RM: Effects of deep sedation or general anesthesia on cardiac function in mice undergoing cardiac magnetic resonance imaging. J Cardiovasc Magnet Res. 2009, 19: 16-10.1186/1532-429X-11-16.CrossRef
10.
go back to reference Higgins CB, Wagner S, Kondo C, Suzuki J, Caputo GR: Evaluation of valvular heart disease with cine gradient echo magnetic resonance imaging. Circulation. 1991, 84 (Suppl I): 198-207. Higgins CB, Wagner S, Kondo C, Suzuki J, Caputo GR: Evaluation of valvular heart disease with cine gradient echo magnetic resonance imaging. Circulation. 1991, 84 (Suppl I): 198-207.
11.
go back to reference Glantz SA: Primer of Biostatistics Version 4.02 for Windows. 1996, New York: McGraw Hill Glantz SA: Primer of Biostatistics Version 4.02 for Windows. 1996, New York: McGraw Hill
12.
go back to reference Freeman RV, Otto CM: Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation. 2005, 111: 3316-3326. 10.1161/CIRCULATIONAHA.104.486738.CrossRefPubMed Freeman RV, Otto CM: Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation. 2005, 111: 3316-3326. 10.1161/CIRCULATIONAHA.104.486738.CrossRefPubMed
13.
go back to reference Kawaguchi A, Miyatake K, Yutani C, Beppu S, Tsushima M, Yamamura T, Yamamoto A: Characteristic cardiovascular manifestation in homozygous and heterozygous familial hypercholesterolemia. Amer H J. 1999, 137: 410-418. 10.1016/S0002-8703(99)70485-0.CrossRef Kawaguchi A, Miyatake K, Yutani C, Beppu S, Tsushima M, Yamamura T, Yamamoto A: Characteristic cardiovascular manifestation in homozygous and heterozygous familial hypercholesterolemia. Amer H J. 1999, 137: 410-418. 10.1016/S0002-8703(99)70485-0.CrossRef
14.
go back to reference Kolansky DM, Cuchel M, Clark BJ, Paridon S, McCrindle BW, Siegers SE, Araujo L, Vohra Y, Defesche JC, Wilson JM, Rader DJ: Longitudinal Evaluation and Assessment of Cardiovascular Disease in Patients With Homozygous Familial Hypercholesterolemia. Am J Cardiol. 2008, 102: 1438-1443. 10.1016/j.amjcard.2008.07.035.CrossRefPubMed Kolansky DM, Cuchel M, Clark BJ, Paridon S, McCrindle BW, Siegers SE, Araujo L, Vohra Y, Defesche JC, Wilson JM, Rader DJ: Longitudinal Evaluation and Assessment of Cardiovascular Disease in Patients With Homozygous Familial Hypercholesterolemia. Am J Cardiol. 2008, 102: 1438-1443. 10.1016/j.amjcard.2008.07.035.CrossRefPubMed
15.
go back to reference Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS: ACC/AHA 2006 Guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2006, 114: e84-231e. 10.1161/CIRCULATIONAHA.106.176857.CrossRefPubMed Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS: ACC/AHA 2006 Guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2006, 114: e84-231e. 10.1161/CIRCULATIONAHA.106.176857.CrossRefPubMed
16.
go back to reference Scognamiglio R, Rahimtoola SH, Fasoli G, Nistri S, Dalla Volta S: Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med. 1994, 331: 1417-1423. 10.1056/NEJM199409153311101.CrossRef Scognamiglio R, Rahimtoola SH, Fasoli G, Nistri S, Dalla Volta S: Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med. 1994, 331: 1417-1423. 10.1056/NEJM199409153311101.CrossRef
17.
go back to reference Evangelista A, Tornos P, Sambola A, Permanyer-Miralda G, Soler-Soler J: Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med. 2005, 353: 1342-1349. 10.1056/NEJMoa050666.CrossRefPubMed Evangelista A, Tornos P, Sambola A, Permanyer-Miralda G, Soler-Soler J: Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med. 2005, 353: 1342-1349. 10.1056/NEJMoa050666.CrossRefPubMed
18.
go back to reference Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum DR, Dupuis J, Long CS, Rubin LJ, Smart FW, Suzuki YJ, Gladwin M, Denholm EM, Gail DB: Right Ventricular Function and Failure: Report of a National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure. Circulation. 2006, 114: 1883-1891. 10.1161/CIRCULATIONAHA.106.632208.CrossRefPubMed Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum DR, Dupuis J, Long CS, Rubin LJ, Smart FW, Suzuki YJ, Gladwin M, Denholm EM, Gail DB: Right Ventricular Function and Failure: Report of a National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure. Circulation. 2006, 114: 1883-1891. 10.1161/CIRCULATIONAHA.106.632208.CrossRefPubMed
19.
go back to reference Ghio S, Gavazzi A, Campana C, Inserra C, Klersy C, Sebastiani R, Arbustini E, Recusani F, Tavazzi L: Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol. 2001, 37: 183-188. 10.1016/S0735-1097(00)01102-5.CrossRefPubMed Ghio S, Gavazzi A, Campana C, Inserra C, Klersy C, Sebastiani R, Arbustini E, Recusani F, Tavazzi L: Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol. 2001, 37: 183-188. 10.1016/S0735-1097(00)01102-5.CrossRefPubMed
20.
go back to reference Haddad F, Denault AY, Couture , Cartier R, Pellerin M, Levesque S, Lambert J, Tardif JC: Right ventricular myocardial performance index predicts perioperative mortality and circulatory failure in high-risk valvular surgery. J Am Soc Echocardiogr. 2007, 20: 1065-1072. 10.1016/j.echo.2007.02.017.CrossRefPubMed Haddad F, Denault AY, Couture , Cartier R, Pellerin M, Levesque S, Lambert J, Tardif JC: Right ventricular myocardial performance index predicts perioperative mortality and circulatory failure in high-risk valvular surgery. J Am Soc Echocardiogr. 2007, 20: 1065-1072. 10.1016/j.echo.2007.02.017.CrossRefPubMed
21.
go back to reference Tanaka K, Sata M, Fukuda D, Suematsu Y, Motomura N, Takamoto S, Hirata Y, Nagai R: Age-associated aortic stenosis in apolipoprotein E-deficient mice. J Am Coll Cardiol. 2005, 46: 134-141. 10.1016/j.jacc.2005.03.058.CrossRefPubMed Tanaka K, Sata M, Fukuda D, Suematsu Y, Motomura N, Takamoto S, Hirata Y, Nagai R: Age-associated aortic stenosis in apolipoprotein E-deficient mice. J Am Coll Cardiol. 2005, 46: 134-141. 10.1016/j.jacc.2005.03.058.CrossRefPubMed
22.
go back to reference Aikawa E, Nahrendorf M, Sosnovik D, Lok VM, Jaffer FA, Aikawa M, Weissleder R: Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation. 2007, 115: 377-386. 10.1161/CIRCULATIONAHA.106.654913.CrossRefPubMed Aikawa E, Nahrendorf M, Sosnovik D, Lok VM, Jaffer FA, Aikawa M, Weissleder R: Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation. 2007, 115: 377-386. 10.1161/CIRCULATIONAHA.106.654913.CrossRefPubMed
23.
go back to reference Jordan MC, Zheng Y, Ryazantsev S, Rozengurt N, Roos KP, Neufeld EF: Cardiac manifestations in the mouse model of mucopolysaccharidosis I. Mol Genet Metab. 2005, 86: 233-43. 10.1016/j.ymgme.2005.05.003.PubMedCentralCrossRefPubMed Jordan MC, Zheng Y, Ryazantsev S, Rozengurt N, Roos KP, Neufeld EF: Cardiac manifestations in the mouse model of mucopolysaccharidosis I. Mol Genet Metab. 2005, 86: 233-43. 10.1016/j.ymgme.2005.05.003.PubMedCentralCrossRefPubMed
Metadata
Title
Biventricular adaptation to volume overload in mice with aortic regurgitation
Authors
Christopher J Berry
Jordan D Miller
KellyAnn McGroary
Daniel R Thedens
Stephen G Young
Donald D Heistad
Robert M Weiss
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Journal of Cardiovascular Magnetic Resonance / Issue 1/2009
Electronic ISSN: 1532-429X
DOI
https://doi.org/10.1186/1532-429X-11-27

Other articles of this Issue 1/2009

Journal of Cardiovascular Magnetic Resonance 1/2009 Go to the issue